<VariationArchive VariationID="1471835" VariationName="NM_005670.4(EPM2A):c.92_124del (p.Arg31_Arg41del)" VariationType="Deletion" Accession="VCV001471835" Version="7" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-28" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1388862" VariationID="1471835">
      <GeneList>
        <Gene Symbol="EPM2A" FullName="EPM2A glucan phosphatase, laforin" GeneID="7957" HGNC_ID="HGNC:3413" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>6q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="145383353" stop="145736023" display_start="145383353" display_stop="145736023" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="145946439" stop="146056990" display_start="145946439" display_stop="146056990" Strand="-" />
          </Location>
          <OMIM>607566</OMIM>
        </Gene>
        <Gene Symbol="EPM2A-DT" FullName="EPM2A divergent transcript" GeneID="100507557" HGNC_ID="HGNC:48990" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>6q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="145734869" stop="145886585" display_start="145734869" display_stop="145886585" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129997381" FullName="ATAC-STARR-seq lymphoblastoid silent region 17642" GeneID="129997381" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>6q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="145734995" stop="145735584" display_start="145734995" display_stop="145735584" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_005670.4(EPM2A):c.92_124del (p.Arg31_Arg41del)</Name>
      <CanonicalSPDI>NC_000006.12:145735374:GCCTCAGGCGGACGGCACCGCGCGGCTCCCAACGCC:GCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="145735375" stop="145735407" display_start="145735375" display_stop="145735407" variantLength="33" positionVCF="145735374" referenceAlleleVCF="GGCCTCAGGCGGACGGCACCGCGCGGCTCCCAAC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="146056511" stop="146056543" display_start="146056511" display_stop="146056543" variantLength="33" positionVCF="146056510" referenceAlleleVCF="GGCCTCAGGCGGACGGCACCGCGCGGCTCCCAAC" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.146056514_146056546del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.146056514_146056546del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.145735378_145735410del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.145735378_145735410del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012832.2" sequenceAccession="NG_012832" sequenceVersion="2" change="g.5449_5481del">
            <Expression>NG_012832.2:g.5449_5481del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001018041.2" sequenceAccession="NM_001018041" sequenceVersion="2" change="c.92_124del">
            <Expression>NM_001018041.2:c.92_124del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001018051.1" sequenceAccession="NP_001018051" sequenceVersion="1" change="p.Arg31_Arg41del">
            <Expression>NP_001018051.1:p.Arg31_Arg41del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001360057.2" sequenceAccession="NM_001360057" sequenceVersion="2" change="c.92_124del">
            <Expression>NM_001360057.2:c.92_124del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001346986.1" sequenceAccession="NP_001346986" sequenceVersion="1" change="p.Arg31_Arg41del">
            <Expression>NP_001346986.1:p.Arg31_Arg41del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001360071.2" sequenceAccession="NM_001360071" sequenceVersion="2" change="c.-578_-546del">
            <Expression>NM_001360071.2:c.-578_-546del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005670.4" sequenceAccession="NM_005670" sequenceVersion="4" change="c.92_124del" MANESelect="true">
            <Expression>NM_005670.4:c.92_124del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005661.1" sequenceAccession="NP_005661" sequenceVersion="1" change="p.Arg31_Arg41del">
            <Expression>NP_005661.1:p.Arg31_Arg41del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001360064.2" sequenceAccession="NM_001360064" sequenceVersion="2" change="c.-114+501_-114+533del">
            <Expression>NM_001360064.2:c.-114+501_-114+533del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368129.2" sequenceAccession="NM_001368129" sequenceVersion="2" change="c.-532_-500del">
            <Expression>NM_001368129.2:c.-532_-500del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368130.1" sequenceAccession="NM_001368130" sequenceVersion="1" change="c.92_124del">
            <Expression>NM_001368130.1:c.92_124del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355059.1" sequenceAccession="NP_001355059" sequenceVersion="1" change="p.Arg31_Arg41del">
            <Expression>NP_001355059.1:p.Arg31_Arg41del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368131.1" sequenceAccession="NM_001368131" sequenceVersion="1" change="c.-276_-244del">
            <Expression>NM_001368131.1:c.-276_-244del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2128649765" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005670.4(EPM2A):c.92_124del (p.Arg31_Arg41del) AND Progressive myoclonic epilepsy" Accession="RCV002002751" Version="7">
        <ClassifiedConditionList TraitSetID="13597">
          <ClassifiedCondition DB="MedGen" ID="C0751778">Progressive myoclonic epilepsy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-14" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10932264</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11175283</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12019207</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14532330</ID>
        </Citation>
        <DescriptionHistory Dated="2024-02-17">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="13597" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3141" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Familial progressive myoclonic epilepsy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myoclonic Epilepsies, Progressive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myoclonus epilepsy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Progressive myoclonus epilepsy</ElementValue>
                <XRef ID="MONDO:0020074" DB="MONDO" />
                <XRef ID="267581004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Progressive myoclonic epilepsy</ElementValue>
                <XRef ID="Progressive+myoclonic+epilepsy/9622" DB="Genetic Alliance" />
                <XRef ID="267581004" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7140" />
                <XRef ID="7140" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NICE, 2022">
                <URL>https://www.nice.org.uk/guidance/ng217</URL>
                <CitationText>UK NICE Guideline NG217, Epilepsies in children, young people and adults, 2022</CitationText>
              </Citation>
              <XRef ID="308" DB="Orphanet" />
              <XRef ID="98261" DB="Orphanet" />
              <XRef ID="C0751778" DB="MedGen" />
              <XRef ID="MONDO:0020074" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS254800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4268147" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="9692702|MedGen:C0751778" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002255935" DateUpdated="2024-02-20" DateCreated="2022-03-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11175283</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10932264</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12019207</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14532330</ID>
          </Citation>
          <Comment>This variant is also known as c.91-123del. This variant, c.92_124del, results in the deletion of 11 amino acid(s) of the EPM2A protein (p.Arg31_Arg41del), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the gnomAD database. This variant has been observed in individual(s) with clinical features of Lafora disease (PMID: 11175283). ClinVar contains an entry for this variant (Variation ID: 1471835). This variant disrupts a region of the EPM2A protein in which other variant(s) (p.Trp32Gly) have been determined to be pathogenic (PMID: 10932264, 12019207, 14532330). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EPM2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.146056511_146056543del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751778" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4268147" TraitType="Disease" MappingType="XRef" MappingValue="C0751778" MappingRef="MedGen">
        <MedGen CUI="C0751778" Name="Progressive myoclonic epilepsy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

